Toshiko Jobo

2.4k total citations · 2 hit papers
70 papers, 1.8k citations indexed

About

Toshiko Jobo is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Toshiko Jobo has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Obstetrics and Gynecology, 35 papers in Reproductive Medicine and 20 papers in Oncology. Recurrent topics in Toshiko Jobo's work include Endometrial and Cervical Cancer Treatments (43 papers), Ovarian cancer diagnosis and treatment (34 papers) and Cervical Cancer and HPV Research (14 papers). Toshiko Jobo is often cited by papers focused on Endometrial and Cervical Cancer Treatments (43 papers), Ovarian cancer diagnosis and treatment (34 papers) and Cervical Cancer and HPV Research (14 papers). Toshiko Jobo collaborates with scholars based in Japan, United States and Sri Lanka. Toshiko Jobo's co-authors include Hiroyuki Kuramoto, Daisuke Aoki, Noriyuki Katsumata, Fumiaki Takahashi, Toru Sugiyama, Makoto Yasuda, Eizo Kimura, Seiji Isonishi, Kazunori Ochiai and Shoji Kodama and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Toshiko Jobo

64 papers receiving 1.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

2009 502 citations Noriyuki Katsumata, Makoto Yasuda et al. The Lancet profile →
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

2013 331 citations Noriyuki Katsumata, Makoto Yasuda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshiko Jobo Japan	20	1.1k	717	636	410	294	70	1.8k
Gabriella Parma Italy	19	869 0.8×	596 0.8×	617 1.0×	350 0.9×	296 1.0×	53	1.6k
Monica B. Jones United States	16	1.1k 1.0×	895 1.2×	363 0.6×	522 1.3×	490 1.7×	22	2.0k
Giovanna Scarfone Italy	28	1.6k 1.5×	987 1.4×	844 1.3×	771 1.9×	377 1.3×	83	2.6k
M. Baekelandt Norway	24	664 0.6×	426 0.6×	525 0.8×	308 0.8×	437 1.5×	55	1.4k
Vanda Salutari Italy	23	722 0.7×	412 0.6×	555 0.9×	291 0.7×	333 1.1×	110	1.5k
Andreas du Bois Germany	9	1.5k 1.4×	572 0.8×	827 1.3×	819 2.0×	328 1.1×	18	2.1k
Gianni Amunni Italy	20	449 0.4×	526 0.7×	358 0.6×	188 0.5×	261 0.9×	55	1.2k
A.G.J. van der Zee Netherlands	24	434 0.4×	318 0.4×	528 0.8×	301 0.7×	593 2.0×	53	1.6k
Stefan Kommoss Germany	24	1.5k 1.4×	1.3k 1.8×	388 0.6×	412 1.0×	461 1.6×	124	2.3k
Hidekatsu Nakai Japan	21	667 0.6×	418 0.6×	445 0.7×	191 0.5×	323 1.1×	75	1.3k

Countries citing papers authored by Toshiko Jobo

Since Specialization

Citations

This map shows the geographic impact of Toshiko Jobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiko Jobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiko Jobo more than expected).

Fields of papers citing papers by Toshiko Jobo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiko Jobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiko Jobo. The network helps show where Toshiko Jobo may publish in the future.

Co-authorship network of co-authors of Toshiko Jobo

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiko Jobo. A scholar is included among the top collaborators of Toshiko Jobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiko Jobo. Toshiko Jobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nomura, Hiroyuki, Daisuke Aoki, Fumiaki Takahashi, et al.. (2010). Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041). Annals of Oncology. 22(3). 636–642. 52 indexed citations

Aoki, Daisuke, Yoh Watanabe, Toshiko Jobo, et al.. (2009). Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.. PubMed. 29(2). 561–6. 5 indexed citations

Katsumata, Noriyuki, Makoto Yasuda, Fumiaki Takahashi, et al.. (2009). Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. The Lancet. 374(9698). 1331–1338. 502 indexed citations breakdown →

Jobo, Toshiko. (2008). Endometrial cytology and biopsy in endometrial carcinoma diagnosis-advantages and disadvantages-. The Journal of the Japanese Society of Clinical Cytology. 47(4). 330–336. 2 indexed citations

Machida, Daisuke, Masaru Yokoyama, Manabu Hattori, et al.. (2008). Adequacy evaluation of endometrial cytology using Thinlayer specimens. The Journal of the Japanese Society of Clinical Cytology. 47(2). 95–102. 1 indexed citations

Tamura, Tomoki, et al.. (2006). Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium. International Journal of Gynecological Cancer. 16(2). 821–826. 16 indexed citations

Watanabe, Jun, Toshiko Jobo, Tsutomu Arai, et al.. (2006). Endometrical cytology with thinlayer method-Usefulness for predicting prognosis of endometrical cancer before therapy-. The Journal of the Japanese Society of Clinical Cytology. 45(4). 242–249. 2 indexed citations

Katsumata, Noriyuki, K Noda, Shunsuke Nozawa, et al.. (2005). Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study. British Journal of Cancer. 93(9). 999–1004. 33 indexed citations

Arai, Tsutomu, et al.. (2004). Endometrial cytology of renal cell carcinoma metastatic to the uterus-A case report-. The Journal of the Japanese Society of Clinical Cytology. 43(6). 397–402.

10.

Watanabe, Jun, et al.. (2004). Cytologic scoring of endometrioid adenocarcinoma of the endometrium. Cancer. 105(1). 8–12. 18 indexed citations

11.

Watanabe, Jun, et al.. (2004). PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. Journal of Cancer Research and Clinical Oncology. 130(3). 161–168. 42 indexed citations

12.

Jobo, Toshiko, et al.. (2003). Clinicopathologic Relevance of Asymptomatic Endometrial Carcinoma. Acta Cytologica. 47(4). 611–615. 7 indexed citations

13.

Arai, Tsutomu, et al.. (2002). Lymphoepithelioma-like carcinoma of the uterine cervix with multiple lymph node metastases. A case report.. The Journal of the Japanese Society of Clinical Cytology. 41(6). 443–447.

14.

Jobo, Toshiko, et al.. (2000). Papillary squamous cell carcinoma of the uterine cervix. A case of report.. The Journal of the Japanese Society of Clinical Cytology. 39(6). 521–526.

15.

Jobo, Toshiko, et al.. (2000). Cytological of endometrial carcinoma. The accuracy of endometrial cytology.. The Journal of the Japanese Society of Clinical Cytology. 39(5). 381–388. 2 indexed citations

16.

Jobo, Toshiko, et al.. (1998). Cytological endometorial heperplasia with new classification. Cytopathological and clinical findings of endometrial hyperplasia.. The Journal of the Japanese Society of Clinical Cytology. 37(6). 637–642. 3 indexed citations

17.

Jobo, Toshiko, et al.. (1993). Cytological analysis of early stage Ib carcinoma of the uterine cervix.. The Journal of the Japanese Society of Clinical Cytology. 32(1). 14–20. 1 indexed citations

18.

Jobo, Toshiko, et al.. (1992). Borderline lesions of endometrial carcinoma and their cytological features.. The Journal of the Japanese Society of Clinical Cytology. 31(1). 11–20. 2 indexed citations

19.

Jobo, Toshiko, et al.. (1988). [Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer].. PubMed. 15(9). 2701–6. 7 indexed citations

20.

Kato, Yoshiki, Toshiko Jobo, & Hiroyuki Kuramoto. (1983). Diagnosis of ovarian carcinoma with endometrial aspiration cytology.. The Journal of the Japanese Society of Clinical Cytology. 22(4). 696–702. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact